301520 萬邦醫藥
按盤價 
45.430 +4.630 (+11.348%)
45.430 +4.630 (+11.348%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.731 | 12.039 | 34.981 | 42.652 | 72.200 |
| 總資產報酬率 ROA (%) | 3.533 | 11.091 | 28.692 | 33.818 | 54.367 |
| 投入資產回報率 ROIC (%) | 3.662 | 11.712 | 32.523 | 37.696 | 60.142 | 邊際利潤分析 |
| 銷售毛利率 (%) | 46.109 | 48.938 | 50.382 | 52.712 | 55.787 |
| 營業利潤率 (%) | 30.497 | 34.817 | 40.679 | 41.300 | 42.726 |
| 息稅前利潤/營業總收入 (%) | 30.668 | 33.654 | 42.280 | 44.489 | 45.044 |
| 淨利潤/營業總收入 (%) | 29.396 | 31.624 | 37.861 | 38.784 | 39.183 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 76.087 | 92.770 | 88.699 | 90.272 | 91.023 |
| 價值變動淨收益/利潤總額(%) | 22.352 | 5.198 | 2.857 | 1.965 | 1.905 |
| 營業外收支淨額/利潤總額(%) | 4.134 | 0.534 | 4.555 | 7.576 | 5.273 | 償債能力分析 |
| 流動比率 (X) | 20.340 | 20.351 | 4.387 | 5.105 | 3.702 |
| 速動比率 (X) | 20.325 | 20.341 | 4.380 | 5.101 | 3.693 |
| 資產負債率 (%) | 5.438 | 5.217 | 18.038 | 17.893 | 24.699 |
| 帶息債務/全部投入資本 (%) | 0.658 | 0.946 | 4.158 | 5.416 | 13.882 |
| 股東權益/帶息債務 (%) | 14,928.160 | 10,378.571 | 2,252.206 | 1,699.051 | 600.072 |
| 股東權益/負債合計 (%) | 1,738.984 | 1,816.848 | 454.373 | 458.873 | 304.875 |
| 利息保障倍數 (X) | -26.802 | -24.926 | -123.982 | -226.532 | -750.687 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 53.052 | 45.530 | 33.319 | 18.819 | 18.712 |
| 存貨周轉天數 (天) | 1.506 | 1.145 | 0.868 | 1.005 | 2.211 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
